NK or CD8 T cell depletion, or IFN-γ neutralization attenuated the PD-L1-targeted NIR-PIT efficacy, as demonstrated by the quantified luciferase activity, and tumor growth and mouse survival data (figure 5B–E). The gene discussed is CD274; the disease is neoplasm.